{{Rsnum
|rsid=589691
|Gene=PYGM
|Chromosome=11
|position=64757744
|Orientation=plus
|GMAF=0.3563
|Gene_s=PYGM,RASGRP2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 19.5 | 79.6
| HCB | 21.3 | 47.8 | 30.9
| JPT | 19.5 | 38.9 | 41.6
| YRI | 65.3 | 32.7 | 2.0
| ASW | 43.9 | 40.4 | 15.8
| CHB | 21.3 | 47.8 | 30.9
| CHD | 17.4 | 52.3 | 30.3
| GIH | 2.0 | 35.6 | 62.4
| LWK | 70.0 | 26.4 | 3.6
| MEX | 5.3 | 42.1 | 52.6
| MKK | 55.8 | 37.8 | 6.4
| TSI | 1.0 | 20.6 | 78.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21768215
|Trait=None
|Title=Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele.
|RiskAllele=T
|Pval=9E-8
|OR=0.1500
|ORtxt=[NR] mg/dl decrease
|OA=1
}}

{{on chip | Illumina Human 1M}}